Top 50 Medical Angel Investors in United Kingdom (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
12 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Ian Hogarth
Angel
|
3 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, E-Commerce, Artificial Intelligence | $668k–$28M |
|
Michael Pennington
Angel
|
2 | United Kingdom, United States, Spain | Seed, Pre-Seed | Software, SaaS, FinTech | $701k–$3M |
|
Alexander Chesterman
Angel
|
2 | United Kingdom, France | Seed, Pre-Seed, Series A | FinTech, E-Commerce, Financial Services | $524k–$23M |
|
Matt Robinson
Angel
|
2 | United Kingdom, United States, Germany | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $650k–$50M |
|
Will Brooks
Angel
|
2 | United Kingdom, United States | Seed, Series A | FinTech, Financial Services, Software | $524k–$30M |
|
Mark Bamforth
Angel
|
2 | United Kingdom, United States | Series A, Seed | Health Care, Medical, Biotechnology | $2M–$19M |
|
Will Martin
Angel
|
2 | United Kingdom, Japan, United States | Seed, Series A | Financial Services, Software, FinTech | $524k–$30M |
|
Matt Clifford
Angel
|
2 | United Kingdom, United States, India | Seed, Pre-Seed | Software, FinTech, Artificial Intelligence | $55k–$7M |
|
Finn Russell
Angel
|
2 | United Kingdom | Angel, Venture - Series Unknown | Fitness, Medical, Wellness | |
|
Taavet Hinrikus
Angel
|
2 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1M–$52M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Software, Social Media, Internet | $455k–$7.9M |
|
Flavien Kulawik
Angel
|
1 | France, United Kingdom | Seed, Series A | Health Care, Artificial Intelligence, SaaS | |
|
Pa Nolan
Angel
|
1 | Ireland, United Kingdom | Seed | Medical, Delivery, Shipping | |
|
Arthur Chen
Angel
|
1 | United Kingdom | Seed, Series A | Medical, Chemical, Software | |
|
Emilio Püschmann
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Nicolaus Henke
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Information Technology, SaaS, Medical | |
|
John Taysom
Angel
|
1 | United Kingdom, United States | Seed, Angel, Series A | Software, Information Technology, Artificial Intelligence | |
|
Peer Schatz
Angel
|
1 | United States, United Kingdom | Seed | Medical, Genetics, Health Care | |
|
Will Armitage
Angel
|
1 | United Kingdom, Chile | Seed, Angel, Pre-Seed | FinTech, Software, Health Care | |
|
Sidar Sahin
Angel
|
1 | United Kingdom | Series A | Medical, mHealth, Health Care | |
|
Andrew MacKay
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Health Care | |
|
Henry Carleton
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
Sachin Agrawal
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
David Prior
Angel
|
1 | Belgium, United Kingdom | Seed | Health Care, Medical, Software | |
|
Johnathan Matlock
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | |
|
Jim Mellon
Angel
|
1 | United States, United Kingdom, Israel | Series A, Seed | Biotechnology, Health Care, Food and Beverage | |
|
Brian Kennedy
Angel
|
1 | United States, United Kingdom | Angel | Music, Medical, Commercial | |
|
Carlos Ballarati
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Yusuf Hamied
Angel
|
1 | United Kingdom | Seed | Medical, Medical Device | |
|
Brian Souter
Angel
|
1 | United Kingdom | Medical, Commercial, Health Care | ||
|
Anand Mahindra
Angel
|
1 | India, United States, United Kingdom | Seed, Angel, Series A | Education, Artificial Intelligence, Social Media | |
|
Inaki Berenguer
Angel
|
1 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | Financial Services, FinTech, E-Commerce | |
|
Alex Macdonald
Angel
|
1 | United Kingdom, United States, France | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, FinTech | |
|
Charlotte Scott
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Pharmaceutical | |
|
Phil Kirby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
|
Robert Marshall
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Harry Glorikian
Angel
|
1 | United States | Series A | SaaS, Content, Analytics | |
|
Paul Thandi
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Peter Job
Angel
|
1 | United Kingdom | Medical, Software, Pharmaceutical | ||
|
Michael Bibby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
|
Simon Kruger
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Amar Shah
Angel
|
1 | United Kingdom, Germany, United States | Pre-Seed, Seed, Angel | Artificial Intelligence, Health Care, Software | |
|
Catherine Lenson
Angel
|
1 | United Kingdom, Israel | Seed, Pre-Seed, Grant | Software, Information Technology, Internet | |
|
Dieter Spälti
Angel
|
1 | United Kingdom | Series A | Medical, Software, Health Care | |
|
Reece Chowdhry
Angel
|
1 | United Kingdom, United States, Canada | Seed, Pre-Seed, Equity Crowdfunding | Software, Financial Services, Artificial Intelligence | $131k–$26M |
|
Stephen Bourke
Angel
|
1 | United Kingdom | Pre-Seed, Angel | Health Care, Medical, Wellness | |
|
Maurice Ferre, M.D.
Angel
|
1 | United States, United Kingdom | Series A, Seed, Angel | Medical Device, Medical, Health Care | $12M–$30M |
|
Tracy Doree
Angel
|
1 | United Kingdom | Seed, Pre-Seed | FinTech, Medical, Wellness | $2.8M–$13M |
|
Robert Taub
Angel
|
1 | Israel, Belgium, United Kingdom | Series A, Series B | Biotechnology, Medical, Hospital | |
| Access all 123 angel investors in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 61
- Round size: Seed $537k–$16M; Series A $4.1M–$50M; Series B $1.6M–$56M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Constructive Bio — We place non-canonical amino acids at precise positions in proteins and peptides to create therapeutics with new properties, then manufacture them through fermentation.
- LIfT BioSciences — LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.LIfT BioSciences was founded in 2016 andheadquartered in London, England.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 55
- Round size: Seed $1.5M–$8.8M; Pre-Seed $668k–$7.7M; Series A $11M–$28M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Blloc — The ultimate smartphone experience. Boost your productivity. Focus on what matters.
- Cordless — Bridging the gap between voice and text
- Heygo — Explore places to visit within the UK and around the world on Rest Less. Get inspired and plan trips to holiday destinations with us.
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 34
- Round size: Seed $750k–$3M; Pre-Seed $701k–$2.1M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- FUEL — Where everlasting fanbases are built
- Sidekick — Expertly-managed portfolios for the modern investor
Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France
Investor stats
- Total investments: 41
- Round size: Seed $524k–$4.8M; Pre-Seed $655k–$3M; Series A $2.3M–$23M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
- Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
- Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 72
- Round size: Seed $1.8M–$7.9M; Pre-Seed $650k–$3M; Series A $6.5M–$50M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Malga — Malga is an online payment platform that offers fraud protection and payment split services.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Malga — Instant access to multiple payment providers with a single integration
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $524k–$3.1M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
- Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.
Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 15
- Round size: Seed $2M–$7M; Series A $9.3M–$19M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- Talking Medicines — Data Science for Life Sciences. Talking Medicines turns unstructured health data into actionable intelligence that proves real marketing impact.
- CONTINUUS Pharmaceuticals — CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUSPharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.
Will Martin - Founder and Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A
- Geography: United Kingdom, Japan, United States
Investor stats
- Total investments: 74
- Round size: Seed $524k–$3.5M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Loadsure — Loadsure is a spot freight cargo insurance company.
- Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.
Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 39
- Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
- Bondaval — Bondaval insures receivables for the world's best credit teams, so they can extend more credit, win more business and get better financing terms.
- Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.
Finn Russell is a Scottish rugby union player.
Show more...Investment focus
- Industry: Fitness, Medical, Wellness
- Stage:Angel, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Puresport — Puresport was created to craft the finest, premium-quality natural products to support every element of wellbeing, from pain & recovery, to sleep, focus, mood, stress, and balance.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 125
- Round size: Seed $1M–$7.9M; Series A $7M–$47M; Series B $23M–$52M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Juro — Juro is an all-in-one contract automation platform that helps legal and business users to agree & manage contracts in one unified workspace.
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Skeleton Technologies — Skeleton Technologies is the global leader in ultracapacitor & supercapacitor energy storage and helps companies in automotive, transportation, grid, and industry to save energy.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Software, Social Media, Internet
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 45
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
- Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
- Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.
Flavien Kulawik
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: France, United Kingdom
Investor stats
- Total investments: 11
- Lead/follow: no public data
Portfolio highlights
- Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
- Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
- Scienta Lab — Redefining precision immunology
Pa Nolan
Show more...Investment focus
- Industry: Medical, Delivery, Shipping
- Stage:Seed
- Geography: Ireland, United Kingdom
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
- Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.
Arthur Chen is a Managing Partner at Ameba Capital.
Show more...Investment focus
- Industry: Medical, Chemical, Software
- Stage:Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Emilio Püschmann
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.
Show more...Investment focus
- Industry: Information Technology, SaaS, Medical
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
- Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
- Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.
John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 16
- Lead/follow: no public data
Portfolio highlights
- LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
- Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
- Worldr — Valarian | Innovating for the new era of digital sovereignty
1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).
Show more...Investment focus
- Industry: Medical, Genetics, Health Care
- Stage:Seed
- Geography: United States, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.
William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.
Show more...Investment focus
- Industry: FinTech, Software, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: United Kingdom, Chile
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
- Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
- Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sidar Sahin is Founder & CEO at Peak Games.
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
Andrew MacKay
Show more...Investment focus
- Industry: Medical, Hospital, Health Care
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
- Materials Nexus — Accelerating change to net-zero materials
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Sachin Agrawal
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
David Prior is the former chair of the UK's National Health Service.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed
- Geography: Belgium, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
- Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Food and Beverage
- Stage:Series A, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
- Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
- The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Brian Kennedy
Show more...Investment focus
- Industry: Music, Medical, Commercial
- Stage:Angel
- Geography: United States, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Gigmor — Booking live music has never been this easy!
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Carlos Ballarati - Founding partner @ Consulta do Bem
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more...Investment focus
- Industry: Medical, Commercial, Health Care
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).
Show more...Investment focus
- Industry: Education, Artificial Intelligence, Social Media
- Stage:Seed, Angel, Series A
- Geography: India, United States, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
- Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
- Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Industry: Financial Services, FinTech, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Alex Macdonald is the Co-Founder and CEO of sequel - an investment platform on a mission to help athletes build a legacy for their families and the world. He previously Co-Founded Velocity Black, raised more than $40m in funding, and which was successfully exited to US Bank Capital One in 2023. He is a serial angel investor having invested in 50early stage startups and funds.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 32
- Lead/follow: no public data
Portfolio highlights
- Kalder — Kalder is a unified web3 brand loyalty platform for brands and creators to drive meaningful engagement, onboard new users, and reward superfan communities.
- Stelia — Stelia stands at the forefront of the AI infrastructure revolution and is driving the transition from Internet 2.0, designed for data movement, to Internet 3.0, designed for data mobility, enabling the seamless flow and processing of data across diverse environments. With its ground-breaking HyperBand platform, Stelia enables businesses toharness the full potential of AI. The company's mission is to become the backbone of the next generation of data mobility, empowering organizations across industries to accelerate innovation, optimize operations, and drive transformative growth. Stelia will be at the gravitational centre of the AI infrastructure ecosystem – a trusted partner and catalyst for change that brings together forward-thinking businesses, technology leaders, and industry experts to shape the future of AI. It was founded in 2021 and is located in London, United Kingdom.
- Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
Charlotte Scott
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Robert Marshall is Executive Chairman of Martlet Capital.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.
Harry Glorikian is the General Partner at Scientia Ventures.
Show more...Investment focus
- Industry: SaaS, Content, Analytics
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- MarketMuse — Our AI-powered software tells you what content to write (and how much) to leverage your experience and rank higher where competitors are weak.
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
- Transparency Life Sciences — Transparency Life Sciences, the first all-digital clinical development services company, harnesses crowdsourcing and mobile health technology to advance biopharma drug candidates through clinical trials with unprecedented patient relevance and efficiency.The TLS model is highly scalable and is designed to increase current industry margins of awasteful process that often collects irrelevant data. Drug companies will outsource an estimated $38B of clinical trial services to CROs by 2020, with a CAGR of 9-10%. Yet this robust growth masks significant customer dissatisfaction. Sponsors want clinical trials to be better-designed, technologically advanced, patient-centric, and significantly less expensive, yet change has been limited by an inability to see beyond the current outmoded, site-centric model.As a consequence, only select compounds are being developed in humans, leaving many potential important therapies untested in clinical trials. Rapid advances in digital technology and strong regulatory support create a historic opportunity for TLS to catalyze a fundamental transformation, significantly improving the quality of clinical trials while reducing their cost.
Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.
Peter Job is an angel investor.
Show more...Investment focus
- Industry: Medical, Software, Pharmaceutical
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Michael Bibby is Chairman at Bibby Line Group Ltd.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Simon Kruger
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Amar is an Entrepreneur in Residence at firstminute focusing on ML and AI technologies. Most recently Amar was CEO and co-founder of Wayve, a company developing an end-to-end machine learning stack for self-driving cars. He was responsible for raising $40 million and building a team of 60 world-class engineers in the UK. Previously Amar has been aQuantitative Strategist at Goldman Sachs, and subsequently completed a PhD in Machine Learning at the University of Cambridge working with Prof Zoubin Ghahramani and Prof Yoshua Bengio, the 2018 winner of the Turing Award. Amar's research was awarded the European Qualcomm Innovation Fellowship in 2015 and the EPSRC Doctoral Prize in 2016. Amar has also applied Machine Learning to the Grand Asteroid Challenge at NASA, where his project was presented in the White House and he won a Planetary Defense Award.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Pre-Seed, Seed, Angel
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- Fractile — Fractile is designing AI compute systems that will enable the next generation of AI scaling: frontier model inference, 25x faster, at 1/10th the cost.
- Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
- Martian Lawyers Club — Home of GUG and Starships TV
Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Pre-Seed, Grant
- Geography: United Kingdom, Israel
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)
- Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
- Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.
Dieter Spälti, Swiss national, born in 1961, Member of the Board of Directors, Member of the Audit Committee, Member of the Governance & Strategy Committee since January 1, 2013. He studied law at the University of Zurich, obtaining a doctorate in 1989. He began his professional career as a credit officer with Bank of New York in New York,before taking up an appointment as CFO of Tyrolit (Swarovski Group), based in Innsbruck and Zurich, in 1991.From 1993 until 2001, he was with McKinsey & Company, ultimately as a partner, and was involved in numerous projects with industrial, financial and technology firms in Europe, the USA and Southeast Asia. In October 2002, he joined Rapperswil-Jona-based Spectrum Value Management Ltd. as a partner, the firm which administers the industrial and private investments of the family of Thomas Schmidheiny.Since 2006, he has been CEO of Spectrum Value Management Ltd. He was elected to the Board of Directors of Holcim Ltd in 2003.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ultromics — Unlock the full potential of echocardiography with groundbreaking solution that simplifies echo reporting. Echo that is precise, fast and accurate.
Reece Lal Chowdhry is based out of London, England and is the Founding Partner of Concept Ventures. Reece previously worked at Ernst & Young as a Management Consultant and Technology Advisory. Reece Lal Chowdhry attended the Durham University. Reece Lal Chowdhry has been awarded as the Seed VC of the Year and Asian Tech Pioneer in their career.
Show more...Investment focus
- Industry: Software, Financial Services, Artificial Intelligence
- Stage:Seed, Pre-Seed, Equity Crowdfunding
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 76
- Round size: Seed $131k–$3.9M; Pre-Seed $500k–$3.4M; Equity Crowdfunding $754k–$26M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Forithmus — Forithmus develops large-scale data infrastructures and foundation model-based artificial intelligence.
- Odin — Community and investment tools for people building the future.
- Reachdesk — Reachdesk enables B2B companies to deliver the moments that matter at scale through data-driven direct mail and gifting. Through Reachdesk companies can deliver gifts and direct mail that build deeper connections with customers, prospects and employees at the click of a button. Our integrations to your tech stack power a clear and quantifiableROI; the direct channel is no longer a guessing game.
Stephen Bourke
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Pre-Seed, Angel
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Habitual — Our diabetes remission programme combines digital therapeutics with diet and habit change. Our personalised programme delivers type 2 diabetes reversal and weight loss.
- Syndi Health — Meet Syndi Health: an all-in-one platform for aggregating, recommending, and paying for digital health services - amplifying your employee wellbeing support with 0% admin.
Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series A, Seed, Angel
- Geography: United States, United Kingdom
Investor stats
- Total investments: 5
- Round size: Series A $12M–$30M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Heru — Elevate Your Eye Care with Heru Prime Next Generation VR Diagnostics
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
- DermaSensor — DermaSensor is an FDA Cleared device for AI skin cancer detection and melanoma detection at the point of care. Non-invasive. Clinically validated.
Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.
Show more...Investment focus
- Industry: FinTech, Medical, Wellness
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Round size: Seed $2.8M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
- Nosso — Nosso is a mobile-based financial planning platform for the future of children.
- The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)
Robert Taub is the Co-Founder and Chairman at Nyxoah.
Show more...Investment focus
- Industry: Biotechnology, Medical, Hospital
- Stage:Series A, Series B
- Geography: Israel, Belgium, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- LifeBond — LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’sdevices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
- ARCHIMEDICX — RateCare is the easiest way to understand hospital quality. We rate, rank and benchmark hospitals with a scientific, unbiased method for important decisions. Our system is powered by a unique and HIMSS certified-unbiased algorithm developed by ARCHIMEDICX, which runs on one of the largest hospital procedural databases. Our data and tools areavailable for patients, hospitals and companies needing to make healthcare price/quality decisions. The RateCare team is dedicated to a patient-centric, transparent and sensible approach to measuring Hospital quality and pricing worldwide. Join us on www.ratecare.com
- EyeD Pharma — We are EyeD Pharma, a clinical stage pharmaceutical company dedicated to improve the life of patients suffering from ophthalmic diseases.
Medical Angel investor funding in United Kingdom at a glance
Stats across 105 deals from 123 investors.
Access all 123 angel investors in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 123 angel investors investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!